Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure

How to buy Axonics Modulation Technologies stock

Learn how to easily invest in Axonics Modulation Technologies stock.

Axonics Modulation Technologies Inc is a medical devices business based in the US. Axonics Modulation Technologies shares (AXNX) are listed on the NASDAQ and all prices are listed in US Dollars. Axonics Modulation Technologies employs 517 staff and has a trailing 12-month revenue of around $217.4 million.

How to buy shares in Axonics Modulation Technologies

  1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – AXNX – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.
Client disclaimer: US Brokerage services through eToro USA Securities Inc, member of FINRA, SIPC. Crypto assets through eToro USA LLC.

Axonics Modulation Technologies stock price (NASDAQ: AXNX)

Use our graph to track the performance of AXNX stocks over time.

Axonics Modulation Technologies shares at a glance

Information last updated 2022-09-25.
Latest market close$70.44
52-week range$38.41 - $79.92
50-day moving average $70.26
200-day moving average $58.65
Wall St. target price$87.13
PE ratio N/A
Dividend yield $0 (0%)
Earnings per share (TTM) $-1.81

Buy Axonics Modulation Technologies shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
1 - 7 of 7
Name Product Asset types Stock trade fee Minimum deposit Signup bonus
SoFi Invest
Stocks, ETFs, Cryptocurrency
$0
$0
$10 - $100
when you open an account and place a first crypto trade of $50 - $5,000+
A free way to invest in most equities.
eToro
Stocks, ETFs, Cryptocurrency
$0
$10
8%-12% of your deposit
when you sign up and deposit at least $50. T&Cs apply.
Trade stocks in the app or online with $0 commissions. Not available in NY, NV, MN, TN, and HI.
Public
Stocks, ETFs, Cryptocurrency
$0
$0
Receive a free stock slice worth between $3–$300
when you sign up for an account and deposit at least $20.
Commission-free trading in stocks and ETFs with a social networking twist.
Tastyworks
Stocks, Options, ETFs, Cryptocurrency
$0
$0
$200 in US stocks
when you open and fund an account with min. $2,000 for 3+ mos.
Trade stocks, options, ETFs and futures on mobile or desktop with this advanced platform.
JPMorgan Self-Directed Investing
Stocks, Bonds, Options, Mutual funds, ETFs
$0
$0
$125 - $625
when you open and fund an account with $25,000 - $250,000+
INVESTMENT AND INSURANCE PRODUCTS ARE: NOT A DEPOSIT • NOT FDIC INSURED • NO BANK GUARANTEE • MAY LOSE VALUE
Robinhood
Stocks, Options, ETFs, Cryptocurrency
$0
$0
Get a free stock
when you successfully sign up and link your bank account.
Make unlimited commission-free trades, plus earn 3% interest on uninvested cash in your account with Robinhood Gold.
Tradier
Stocks, Options, ETFs
$0
$0
N/A
Customize your trade platform or build your own Deep tools, charts and screens Analyzers to help you study before you trade
loading

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Axonics Modulation Technologies stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Axonics Modulation Technologies price performance over time

Historical closes compared with the close of $70.44 from 2022-09-30

1 week (2022-09-23) 7.97%
1 month (2022-09-02) -0.30%
3 months (2022-07-01) 21.53%
6 months (2022-03-29) N/A
1 year (2021-10-01) 5.40%
2 years (2020-10-02) 44.64%
3 years (2019-10-02) 177.98%
5 years (2017-09-28) N/A

Axonics Modulation Technologies financials

Revenue TTM $217.4 million
Gross profit TTM $115.7 million
Return on assets TTM -7.75%
Return on equity TTM -16.25%
Profit margin -35.19%
Book value $9.29
Market capitalisation $3.2 billion

TTM: trailing 12 months

Axonics Modulation Technologies share dividends

We're not expecting Axonics Modulation Technologies to pay a dividend over the next 12 months.

Axonics Modulation Technologies share price volatility

Over the last 12 months, Axonics Modulation Technologies's shares have ranged in value from as little as $38.41 up to $79.92. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Axonics Modulation Technologies's is 0.4153. This would suggest that Axonics Modulation Technologies's shares are less volatile than average (for this exchange).

Axonics Modulation Technologies overview

Axonics, Inc. , a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems. The company's SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence and non-obstructive urinary retention. Its proprietary rechargeable SNM System (r-SNM) delivers mild electrical pulses to the targeted sacral nerve to restore normal communication to and from the brain to reduce the symptoms of bladder and bowel dysfunction. The company also offers Bulkamid, a urethral bulking agent to treat female stress urinary incontinence. It sells its products through a direct salesforce and distributors in the United States, the United Kingdom, Germany, the Netherlands, Nordic countries, and internationally. The company was formerly known as Axonics Modulation Technologies, Inc.

Frequently asked questions

What percentage of Axonics Modulation Technologies is owned by insiders or institutions?
Currently 4.162% of Axonics Modulation Technologies shares are held by insiders and 107.027% by institutions.
How many people work for Axonics Modulation Technologies?
Latest data suggests 517 work at Axonics Modulation Technologies.
When does the fiscal year end for Axonics Modulation Technologies?
Axonics Modulation Technologies's fiscal year ends in December.
Where is Axonics Modulation Technologies based?
Axonics Modulation Technologies's address is: 26 Technology Drive, Irvine, CA, United States, 92618
What is Axonics Modulation Technologies's ISIN number?
Axonics Modulation Technologies's international securities identification number is: US05465P1012
What is Axonics Modulation Technologies's CUSIP number?
Axonics Modulation Technologies's Committee on Uniform Securities Identification Procedures number is: 05465P101

More guides on Finder

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site